Annotation Detail for DGKD

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00561 | Glycerolipid metabolism |
hsa00564 | Glycerophospholipid metabolism |
hsa01100 | Metabolic pathways |
hsa04070 | Phosphatidylinositol signaling system |
Pathway ID | Pathway Name |
---|
| Signaling by GPCR |
| Hemostasis |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DGKD mRNA | decreases expression | 19150397
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DGKD mRNA | increases expression | 18301758
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.72 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.37 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.70 | 19483382 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
3.04 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.19 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.61 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
3.02 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.16 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.31 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.81 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.76 | 19176532 16221962 18467677 19772884 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.69 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.93 | 16306350 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.95 | 16377806 15890375 20007298 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.27 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.30 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.33 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.14 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.90 | 20558911 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.58 | 19058328 |
PharmGKB Accession:PA27312
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00144 |
- |
Phosphatidylserine |
Dietary supplement;Micronutrient |